Special Report on the Impact of the COVID-19 Pandemic on Clinical EEG and Research and Consensus Recommendations for the Safe Use of EEG.
Por:
Campanella S, Arikan K, Babiloni C, Balconi M, Bertollo M, Betti V, Bianchi L, Brunovsky M, Buttinelli C, Comani S, Di Lorenzo G, Dumalin D, Escera C, Fallgatter A, Fisher D, Giordano GM, Guntekin B, Imperatori C, Ishii R, Kajosch H, Kiang M, López-Caneda E, Missonnier P, Mucci A, Olbrich S, Otte G, Perrottelli A, Pizzuti A, Pinal D, Salisbury D, Tang Y, Tisei P, Wang J, Winkler I, Yuan J and Pogarell O
Publicada:
1 ene 2021
Ahead of Print:
25 sep 2020
Resumen:
INTRODUCTION: The global COVID-19 pandemic has affected the economy, daily life, and mental/physical health. The latter includes the use of electroencephalography (EEG) in clinical practice and research. We report a survey of the impact of COVID-19 on the use of clinical EEG in practice and research in several countries, and the recommendations of an international panel of experts for the safe application of EEG during and after this pandemic. METHODS: Fifteen clinicians from 8 different countries and 25 researchers from 13 different countries reported the impact of COVID-19 on their EEG activities, the procedures implemented in response to the COVID-19 pandemic, and precautions planned or already implemented during the reopening of EEG activities. RESULTS: Of the 15 clinical centers responding, 11 reported a total stoppage of all EEG activities, while 4 reduced the number of tests per day. In research settings, all 25 laboratories reported a complete stoppage of activity, with 7 laboratories reopening to some extent since initial closure. In both settings, recommended precautions for restarting or continuing EEG recording included strict hygienic rules, social distance, and assessment for infection symptoms among staff and patients/participants. CONCLUSIONS: The COVID-19 pandemic interfered with the use of EEG recordings in clinical practice and even more in clinical research. We suggest updated best practices to allow safe EEG recordings in both research and clinical settings. The continued use of EEG is important in those with psychiatric diseases, particularly in times of social alarm such as the COVID-19 pandemic.
Filiaciones:
Campanella S:
Laboratoire de Psychologie Médicale et d'Addictologie, ULB Neuroscience Institute (UNI), CHU Brugmann-Université Libre de Bruxelles (U.L.B.), Belgium
Arikan K:
Kemal Arikan Psychiatry Clinic, Istanbul, Turkey
Babiloni C:
Department of Physiology and Pharmacology "Erspamer", Sapienza University of Rome, Italy
San Raffaele Cassino, Cassino (FR), Italy
Balconi M:
Research Unit in Affective and Social Neuroscience, Department of Psychology, Catholic University of Milan, Milan, Italy
Bertollo M:
BIND-Behavioral Imaging and Neural Dynamics Center, Department of Neuroscience, Imaging and Clinical Sciences, University "G. d'Annunzio" of Chieti-Pescara, Chieti, Italy
Betti V:
Department of Psychology, Sapienza University of Rome, Fondazione Santa Lucia, Rome, Italy
Bianchi L:
Dipartimento di Ingegneria Civile e Ingegneria Informatica (DICII), University of Rome Tor Vergata, Rome, Italy
Brunovsky M:
National Institute of Mental Health, Klecany Czech Republic
Third Medical Faculty, Charles University, Prague, Czech Republic
Buttinelli C:
Department of Neurosciences, Public Health and Sense Organs (NESMOS), Sapienza University of Rome, Rome, Italy
Comani S:
BIND-Behavioral Imaging and Neural Dynamics Center, Department of Neuroscience, Imaging and Clinical Sciences, University "G. d'Annunzio" of Chieti-Pescara, Chieti, Italy
Di Lorenzo G:
Laboratory of Psychophysiology and Cognitive Neuroscience, Chair of Psychiatry, Department of Systems Medicine, School of Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy
IRCCS Fondazione Santa Lucia, Rome, Italy
Dumalin D:
AZ Sint-Jan Brugge-Oostende AV, Campus Henri Serruys, Lab of Neurophysiology, Department Neurology-Psychiatry, Ostend, Belgium
Escera C:
Brainlab-Cognitive Neuroscience Research Group, Department of Clinical Psychology and Psychobiology, Institute of Neurosciences, University of Barcelona, Barcelona, Spain
Fallgatter A:
Department of Psychiatry, University of Tübingen, Germany
LEAD Graduate School and Training Center, Tübingen, Germany
German Center for Neurodegenerative Diseases DZNE, Tübingen, Germany
Fisher D:
Department of Psychology, Mount Saint Vincent University, and Department of Psychiatry, Nova Scotia Health Authority, Halifax, Nova Scotia, Canada
Giordano GM:
Department of Psychiatry, University of Campania "Luigi Vanvitelli", Naples, Italy
Guntekin B:
Department of Biophysics, School of Medicine, Istanbul Medipol University, Istanbul, Turkey
Imperatori C:
Cognitive and Clinical Psychology Laboratory, Department of Human Science, European University of Rome, Rome, Italy
Ishii R:
Department of Psychiatry Osaka University Graduate School of Medicine, Osaka, Japan
Kajosch H:
Laboratoire de Psychologie Médicale et d'Addictologie, ULB Neuroscience Institute (UNI), CHU Brugmann-Université Libre de Bruxelles (U.L.B.), Belgium
Kiang M:
Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada
López-Caneda E:
Psychological Neuroscience Laboratory, Center for Research in Psychology, School of Psychology, University of Minho, Braga, Portugal
Missonnier P:
Mental Health Network Fribourg (RFSM), Sector of Psychiatry and Psychotherapy for Adults, Marsens, Switzerland
Mucci A:
Department of Psychiatry, University of Campania "Luigi Vanvitelli", Naples, Italy
Olbrich S:
Psychotherapy and Psychosomatics, Department for Psychiatry, University Hospital Zurich, Zurich, Switzerland
Otte G:
Group "Neurotope", Ghent, Belgium
Perrottelli A:
Department of Psychiatry, University of Campania "Luigi Vanvitelli", Naples, Italy
Pizzuti A:
Department of Psychology, Sapienza University of Rome, Fondazione Santa Lucia, Rome, Italy
Pinal D:
Psychological Neuroscience Laboratory, Center for Research in Psychology, School of Psychology, University of Minho, Braga, Portugal
Salisbury D:
Clinical Neurophysiology Research Laboratory, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
Tang Y:
Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Tisei P:
Department of Neurosciences, Public Health and Sense Organs (NESMOS), Sapienza University of Rome, Rome, Italy
Wang J:
Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Winkler I:
Institute of Cognitive Neuroscience and Psychology, Research Centre for Natural Sciences, Budapest, Hungary
Yuan J:
Institute of Brain and Psychological Sciences, Sichuan Normal University, Chengdu, China
Pogarell O:
Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany
Open Access
|